Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA : vimarsana.com

TORRANCE, Calif., May 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, announced today that it has received a Medicine Registration... | June 7, 2023

Related Keywords

United States , Saudi Arabia , India , Kuwait , United Arab Emirates , Israel , Qatar , Bahrain , State Of Qatar , Saudi , Americans , Kingdom Of Bahrain , Kingdom Of Saudi Arabia , Willis Lee , Yutaka Niihara , George Sekulich , Bahrain National Health Regulatory Authority , Blueprint For Action National Academy Of Sciences , Centers For Disease , Emmaus Life Sciences , Committee On Addressing Sickle Cell Disease , Exchange Commission , National Center On Birth Defects , Emmaus Life Sciences Inc , Company Contact , Medicine Registration Certificate , Chief Executive Officer , Middle East , North Africa , Senior Vice President , Global Commercialization , Gulf Pharmacies , Life Sciences , Prescribing Information , Sickle Cell Disease , National Center , Birth Defects , Developmental Disabilities , Disease Control , Addressing Sickle Cell Disease , Strategic Plan , Sciences Press , Private Securities Litigation Reform Act , Operating Officer ,